| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation
|
Yoshimura, Yasushi
|
|
2016
|
77 |
3 |
p. 623-628
|
artikel
|
| 2 |
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors
|
Bruce, Justine Yang
|
|
2016
|
77 |
3 |
p. 527-538
|
artikel
|
| 3 |
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer
|
Shim, Hyun-Jeong
|
|
2016
|
77 |
3 |
p. 605-612
|
artikel
|
| 4 |
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
|
Heo, Su Jin
|
|
2016
|
77 |
3 |
p. 539-548
|
artikel
|
| 5 |
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors
|
Luke, Jason J.
|
|
2016
|
77 |
3 |
p. 549-558
|
artikel
|
| 6 |
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities
|
Lu, Dan
|
|
2016
|
77 |
3 |
p. 459-476
|
artikel
|
| 7 |
Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance
|
Zhang, Quan
|
|
2016
|
77 |
3 |
p. 583-593
|
artikel
|
| 8 |
Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab
|
Agrawal, Shruti
|
|
2016
|
77 |
3 |
p. 635-641
|
artikel
|
| 9 |
Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription
|
Ye, Pingjiang
|
|
2016
|
77 |
3 |
p. 613-621
|
artikel
|
| 10 |
Human mass balance study of TAS-102 using 14C analyzed by accelerator mass spectrometry
|
Lee, James J.
|
|
2016
|
77 |
3 |
p. 515-526
|
artikel
|
| 11 |
Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma
|
Shang, Chao
|
|
2016
|
77 |
3 |
p. 507-513
|
artikel
|
| 12 |
Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer
|
Stroh, Mark
|
|
2016
|
77 |
3 |
p. 485-494
|
artikel
|
| 13 |
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
|
Said, Rabih
|
|
2016
|
77 |
3 |
p. 575-581
|
artikel
|
| 14 |
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
|
Ueno, Hideki
|
|
2016
|
77 |
3 |
p. 595-603
|
artikel
|
| 15 |
Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy
|
Takagi, Yusuke
|
|
2016
|
77 |
3 |
p. 559-564
|
artikel
|
| 16 |
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
|
Belli, Carmen
|
|
2015
|
77 |
3 |
p. 477-484
|
artikel
|
| 17 |
Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma
|
Liang, Zibin
|
|
2016
|
77 |
3 |
p. 643-651
|
artikel
|
| 18 |
Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice
|
Rocha, Viviane Costa Junqueira
|
|
2015
|
77 |
3 |
p. 659-662
|
artikel
|
| 19 |
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors
|
Arnhold, Viktor
|
|
2016
|
77 |
3 |
p. 495-505
|
artikel
|
| 20 |
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
|
Phillips, Roger M.
|
|
2016
|
77 |
3 |
p. 441-457
|
artikel
|
| 21 |
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer
|
Giovinazzo, Hugh
|
|
2016
|
77 |
3 |
p. 565-573
|
artikel
|
| 22 |
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy
|
Dalla Pria, Alessia
|
|
2015
|
77 |
3 |
p. 653-657
|
artikel
|
| 23 |
UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy
|
Zhang, Ling
|
|
2016
|
77 |
3 |
p. 629-634
|
artikel
|
Tijdschrift beschrijving